Francesco Ardito

Plain English
This study looked at different types of cholangiocarcinoma (CCA), a type of bile duct cancer, to see how their characteristics affect patient outcomes. Researchers analyzed data from 293 patients and found that a specific subtype of intrahepatic CCA (called PAS HIGH LBD iCCA) had a much worse chance of survival over five years compared to others, with significantly poorer outcomes tied to this subtype. Understanding these differences helps doctors better predict patient prognosis and tailor treatments accordingly. Who this helps: This benefits patients with cholangiocarcinoma and their doctors by providing clearer insights into their condition.

Plain English
This study compared two types of chemotherapy given before surgery for patients with colorectal cancer that has spread to the liver. It found that patients who received the FOLFOXIRI treatment had a higher rate of successful major liver surgeries (44.4% compared to 35.3%) and better long-term survival rates (66.6% over five years compared to 56.4%) despite experiencing more significant blood loss and a few more transfusions during surgery. This matters because choosing the right chemotherapy before surgery can improve outcomes for patients with liver metastases. Who this helps: Patients with colorectal liver metastases.

Plain English
Researchers studied how to use machine learning to predict microvascular invasion (MVI) in patients with liver cancer before surgery by analyzing CT scans. They found that their best machine learning model, called Random-Forest, accurately identified MVI 96.8% of the time, which is significant since MVI is a major factor affecting patient survival and recurrence after surgery. This advancement could help doctors make better decisions about treatment plans and follow-up for liver cancer patients. Who this helps: Patients with hepatocellular carcinoma and their doctors.

Plain English
This study looked at how to predict liver failure after surgery in patients with liver cancer using advanced computer techniques and scans. Researchers examined 500 scans and found that 17 patients (or 3.4%) experienced liver failure after surgery. The best predictive model (a combination of two machine-learning approaches) had an impressive accuracy rate of 89.2%, which could help doctors identify which patients are likely to recover well from surgery and which ones might face complications. Who this helps: This helps patients with liver cancer and their doctors in making better treatment decisions.

Plain English
This study compared two types of liver surgery for patients with liver cancer, known as hepatocellular carcinoma. It found that minimally invasive surgery (MALS) resulted in fewer complications after simpler procedures (53.2% of cases) and fewer major complications for more complex cases (20.5% of cases). However, for the most complex procedures (26.2%), MALS increased the risk of serious complications, especially in lower-volume hospitals. These findings highlight that the type of surgery and the hospital's experience can significantly impact patient recovery after liver cancer surgery. Who this helps: This information helps patients and doctors make more informed choices about liver cancer surgery options.

Plain English
This study compared two types of liver surgery for patients with a type of liver cancer called hepatocellular carcinoma (HCC) that has not spread to other organs. Researchers analyzed data from 627 patients, finding that minimally invasive liver surgery (MILS) did not lead to more complications or longer hospital stays than traditional open liver resection (OLR). However, MILS resulted in significantly fewer blood transfusions and less fluid buildup after surgery. Who this helps: This benefits patients with non-metastatic liver cancer by offering a safer surgical option.

Plain English
This study looked at the results of liver surgeries performed on 164 patients with a specific liver stone condition called hepatolithiasis. Researchers found that using minimally invasive techniques, which are less invasive than traditional surgery, made a significant difference: these patients experienced fewer complications and shorter hospital stays, with 60% of surgeries in the latest period being minimally invasive. There was a 20% rate of recurrence for stones after surgery, particularly when the stones were not fully cleared. Who this helps: This research benefits patients suffering from liver stones and doctors by providing insights into effective surgical approaches.

Plain English
This study looked at different ways to evaluate the risks associated with liver surgery for patients with liver cancer in Italy, focusing on 3,280 surgeries. Researchers found that traditional classifications for liver surgery, which rely on how much liver tissue is removed, work well for open surgeries but do not effectively predict outcomes for minimally invasive surgeries—where patient safety is harder to assess. This is important because understanding these risks can help improve patient care and surgical planning. Who this helps: This benefits patients undergoing liver surgery and their doctors.

Plain English
This study examined how to predict the risk of lymph node metastases (LNM) in patients with a specific type of liver cancer, known as intrahepatic cholangiocarcinoma, who are scheduled for surgery. Researchers reviewed data from 693 patients and found that factors such as the level of a blood marker (CA 19-9), the condition of lymph nodes seen in imaging tests, age, and the extent of the tumor were linked to the likelihood of LNM. The model developed to assess risk showed fairly high accuracy, which can help doctors make better decisions about treating these patients. Who this helps: This benefits patients undergoing surgery for intrahepatic cholangiocarcinoma and their doctors.

Plain English
This study looked at how MRI scans can help predict how well colorectal cancer that has spread to the liver responds to chemotherapy before surgery. Researchers found that out of 131 patients who showed some signs of tumor shrinkage on their scans, 45% actually had no real tumor reduction when examined after surgery. Using a combination of clinical data and advanced MRI analysis produced an accuracy rate of 77% in predicting true tumor response, which is better than using clinical data alone. Who this helps: This benefits patients with colorectal liver metastases and their doctors by providing a more accurate way to assess treatment effectiveness before surgery.

Plain English
This study looked at how patients with colorectal cancer that has spread to the liver did when treated at a specialized medical center. Researchers analyzed data from 613 patients and found that those who received comprehensive care at the center had a better chance of living at least five years after treatment—54.5% compared to 44.6% for those who did not receive the same level of internal management. This matters because better management can lead to improved survival rates for patients facing this challenging condition. Who this helps: Patients with synchronous colorectal liver metastases.

Plain English
This study examined how surgeons around the world use preoperative chemotherapy to treat a type of liver cancer called intrahepatic cholangiocarcinoma (iCCA). Out of 167 surgeons surveyed, 91.6% stated they typically use chemotherapy for patients whose tumors are initially inoperable, and 74.8% would use it to improve surgical outcomes. Defining when a tumor cannot be removed is complicated, but using chemotherapy can help shrink tumors and choose the best candidates for surgery, potentially increasing the chances of successful removal. Who this helps: This benefits patients with intrahepatic cholangiocarcinoma.

Plain English
This study looked at how different surgical methods for removing incidental gallbladder cancer (iGBC) affect patients' recovery and long-term health outcomes. Researchers compared traditional open surgery with minimally invasive techniques used on 95 patients over 25 years and found that while minimally invasive surgery took longer, it resulted in shorter hospital stays without affecting the chances of surviving cancer or having it come back. Overall, the type of surgery didn't change patients' long-term outcomes; instead, factors like tumor stage and lymph node involvement were more important. Who this helps: This benefits patients with incidental gallbladder cancer and surgeons performing these procedures.

Plain English
This study focused on methods to encourage the liver to grow larger before surgery to remove part of it (hepatectomy). Researchers found that there are many different techniques being used by surgeons, but there's a lack of consistent safety standards or guidelines for how to apply them. Establishing clear guidelines for these techniques is important because it could improve patient outcomes during liver surgeries. Who this helps: This helps patients undergoing liver surgery.

Plain English
This study looked at patients who had surgery for a type of liver cancer called intrahepatic cholangiocarcinoma (ICC) to see if certain pre-surgery health factors could predict if their cancer would come back quickly, within six months. Researchers analyzed data from 83 patients and found that about 20% (17 patients) experienced very early recurrence, which is linked to a much worse survival rate—0% for those with early recurrence compared to nearly 49% for those without. The study concluded that just looking at pre-surgery health factors is not enough to predict early cancer recurrence, suggesting a need for better methods that consider more detailed patient data. Who this helps: This information is valuable for doctors and patients facing surgery for intrahepatic cholangiocarcinoma.

Plain English
This study looked at how a team of different cancer specialists, called a multidisciplinary tumor board (MDTB), affects the treatment of colorectal cancer. They reviewed 1,150 cases between 2019 and 2023 and found that after the MDTB meetings, treatment decisions changed in 325 cases, leading to a discrepancy rate of 28.3%. These changes, particularly in decisions about imaging, surgery, and radiation, show that teamwork among specialists can significantly improve treatment planning for patients. Who this helps: This helps patients with colorectal cancer by ensuring they receive the best possible treatment options.

Plain English
This study looked at how well patients with metastatic colorectal cancer (mCRC) do after having surgery to remove tumors, specifically focusing on those who had the surgery done more than once. Out of nearly 1,600 patients, 143 underwent at least two surgeries; they had a median time without cancer recurrence of 8.2 months after the second surgery and a 5-year survival rate of 73.1%. The research highlights that repeated surgeries can significantly improve survival for certain patients, and using a scoring system can help doctors choose who would benefit most from such procedures. Who this helps: This helps patients with metastatic colorectal cancer and their doctors.

Plain English
This study compared two different surgical techniques for removing liver tumors in patients with hepatocellular carcinoma (HCC): robotic liver resection (RLR) and laparoscopic liver resection (LLR). Researchers looked at outcomes from 647 patients and found that RLR resulted in wider surgical margins (10 mm vs. 5 mm), lower rates of conversion to open surgery (2.1% vs. 8.5%), shorter hospital stays (4 days vs. 5 days), and significantly better recurrence-free survival after five years (46.8% for RLR compared to 24.0% for LLR). This is important because better margins and lower recurrence rates can lead to improved long-term outcomes for patients with HCC. Who this helps: This helps patients with liver cancer and their doctors by providing insights into more effective surgical options.

Plain English
This study looked at two treatment options for patients with small single liver tumors called hepatocellular carcinoma (HCC) that are 3 cm or smaller. Researchers compared surgical removal of the tumor (laparoscopic resection) to a less invasive method using heat to destroy the tumor (thermoablation) in 1,465 patients. They found that patients who had the tumor surgically removed lived longer (median of 93 months) and had a longer time without the cancer returning (39 months) compared to those who had thermoablation (median overall survival of 60 months and recurrence-free survival of 26 months). Who this helps: This research benefits patients with small liver tumors by highlighting the importance of surgical options for better long-term outcomes.

Plain English
This study looked at a rare condition called hepatic splenosis, which can look like liver cancer on imaging tests. Researchers reviewed past cases and presented one of a 52-year-old man who had a liver lesion that seemed like cancer but turned out to be splenic tissue in the liver. Recognizing splenosis in patients without liver disease can avoid unnecessary surgeries and help doctors manage these cases better. Who this helps: Patients who have had their spleen removed and develop liver lesions.

Plain English
This study looked at a new tool called the LC-CVS OPSA, which evaluates the safety of surgeons performing laparoscopic gallbladder removal (cholecystectomy) by analyzing surgery videos. The tool includes six specific safety checks, and it proved to be very reliable when assessed by a team of 12 expert surgeons, with agreement scores for different checks ranging from 0.76 to 0.86. This is important because it helps ensure that surgeons are being trained to perform these procedures safely, ultimately improving patient outcomes. Who this helps: This helps patients by ensuring that surgeons are better trained in safe surgical practices.

Plain English
Researchers studied how expert surgeons determine whether laparoscopic gallbladder surgery techniques are "safe" or "unsafe" using a new assessment tool. Out of 660 evaluations of surgical videos, 238 were marked as "unsafe," with common reasons including failure to achieve a safe view during surgery or using less-than-ideal techniques. This matters because refining these scoring guidelines can lead to better surgical training, ultimately improving patient safety and outcomes. Who this helps: Patients undergoing laparoscopic gallbladder surgery.

Plain English
This study looked at how surgical treatments for benign liver lesions have changed over time, particularly focusing on the increased use of laparoscopic surgery. Researchers analyzed data from 845 patients treated in three time periods between 2008 and 2019 and found that while the overall rate of successful surgical outcomes remained consistent (around 81-86%), the rate of exceptional outcomes improved significantly, from 41.7% to 58.7%. Additionally, there was an increase in laparoscopic surgeries from 57.8% to 77%, and the average hospital stay decreased from 5 to 4 days. Who this helps: This benefits patients undergoing surgery for benign liver conditions, providing them with less invasive options and quicker recoveries.

Plain English
This study looked at the effectiveness of two liver cancer treatments: liver transplantation (LT) and liver resection (LR). The research found that patients who received a liver transplant had better chances of living for five years and being free of cancer compared to those who had liver surgery. Specifically, the overall survival rate for LT was about 79% compared to 63% for early-stage cancer surgery. This is important because it highlights that liver transplants can lead to higher survival rates for patients with liver cancer, which is crucial given the limited availability of donor organs. Who this helps: This helps liver cancer patients and their doctors make more informed treatment decisions.

Plain English
This study looked at how to predict serious complications after liver surgery (hepatectomy) by analyzing data from 411 patients. They found that 19% of patients experienced severe complications within 30 days after surgery. By using early data from the Intensive Care Unit, such as body mass index and specific blood test results, they created a new scoring system that can help identify which patients are at higher risk for these complications. Who this helps: This helps patients and doctors by improving risk assessment after liver surgery.

Plain English
This study looked at the costs and outcomes of robotic liver surgery compared to traditional open surgery and laparoscopic surgery in patients undergoing complex liver operations. Researchers analyzed data from two hospitals and found that robotic surgery, while initially more expensive (costing about €10,637 compared to €9,543 for laparoscopic and €13,960 for open surgery), resulted in less blood loss, lower rates of complications, and shorter hospital stays, making it more cost-effective overall. This is important because it shows that, despite higher upfront costs, robotic surgery can lead to better recovery and reduced hospital costs over time. Who this helps: This benefits patients undergoing complex liver surgeries and their doctors.

Plain English
This study looked at the risks and outcomes of surgeries involving the liver in patients with advanced ovarian cancer. Researchers analyzed data from 615 patients and found that 15% experienced problems during surgery, and 17.6% had serious complications afterward. It turns out that specific types of liver involvement (Classes II and IV) were linked to higher rates of severe complications and longer surgeries, indicating that understanding these patterns can help improve patient care during such complex procedures. Who this helps: This helps doctors and patients by providing insights into surgical risks associated with advanced ovarian cancer.

Plain English
This study examined how certain features from CT scans of intrahepatic cholangiocarcinoma (ICC) and its surrounding tissue can better predict patient survival after surgery. Researchers analyzed data from 215 patients and found that after three years, 57% were still alive, and about 35% remained free of cancer progression. By incorporating specialized imaging features into the survival predictions, the accuracy improved significantly, matching results typically obtained after surgery. Who this helps: This helps patients with ICC and their doctors by providing better predictions for survival post-surgery.

Plain English
Researchers studied whether surgery could be beneficial for patients with pancreatic cancer that has spread only to the liver, a condition called oligo-metastatic pancreatic ductal adenocarcinoma (PDAC). They found that in a select group of patients who had received chemotherapy before surgery, there were promising outcomes, but they emphasized the need for clear definitions and more research regarding treatment approaches. This is important because it opens up potential new treatment options for patients whose cancer has spread in limited ways and could improve their survival chances. Who this helps: Patients with liver-only metastatic pancreatic cancer.

Plain English
This study looked at the use of robotic surgery to treat patients with recurrent gynecological cancers over a ten-year period. Of the 54 patients treated, all were successful in having their tumors removed completely, with an overall survival rate of 72.3% after two years. The findings highlight that robotic surgery can be an effective option for these patients, especially those with fewer cancer spread areas and who are treated at experienced medical centers. Who this helps: This benefits women with recurrent gynecological cancers, particularly those in need of a less invasive surgical option.

Plain English
This study looks at various factors that can help predict how well patients will do after surgery to remove liver tumors caused by hepatocellular carcinoma (HCC). It found that while traditional markers like certain tumor characteristics and alpha-fetoprotein levels are still important, newer markers like inflammation indicators and liquid biopsy techniques show promise for predicting outcomes. About 70% of patients experience a recurrence of the cancer after surgery, so finding reliable ways to assess prognosis is crucial for guiding treatment decisions. Who this helps: This helps doctors and patients dealing with liver cancer.

Plain English
This study looked at how different surgical methods for liver removal affect liver damage after surgery. It found that patients who had minimally invasive liver surgery (MILS) had much lower levels of a liver enzyme called ALT on the first, third, and fifth days after surgery compared to those who had traditional open surgery: for example, the median ALT level was 301 in the open surgery group versus 187 in the MILS group on the first postoperative day. This matters because lower ALT levels indicate less liver injury, which can lead to quicker recovery and fewer complications. Who this helps: This benefits patients undergoing liver surgery.

Plain English
This study focused on how to treat large liver tumors (specifically larger than 5 cm) effectively. Researchers looked at 535 patients and found that performing major liver surgery led to more serious complications without providing better long-term survival compared to smaller, less invasive surgeries. They concluded that, when possible, smaller surgeries should be the preferred option since they result in fewer complications while offering similar outcomes. Who this helps: This benefits patients with large liver tumors by reducing their risk of complications from surgery.

Plain English
This study looked at patients who underwent liver surgery to see how surgical complexity and nutritional health could help predict complications after the procedure. Out of 1,258 patients, 570 (about 45%) had complications, with 506 needing treatment. Researchers found that using a model based on liver surgery complexity and certain nutritional factors (like cholinesterase and albumin levels) could predict complications more accurately than standard nutritional assessments. For example, patients with good cholinesterase levels were estimated to have 5-15% fewer complications than those with lower levels. Who this helps: This helps doctors better predict and manage complications for patients undergoing liver surgery.

Plain English
This study looked at a new device called the CUSA Clarity Ultrasonic Surgical Aspirator, which is used during liver surgeries to help remove tissue and minimize blood loss. Researchers examined 100 patients over a period of 1 year and 8 months and found that surgeons successfully removed all the targeted tissue in 95% of cases, with an average surgery time of about 4 hours and 34 minutes, and no complications reported. This is important because it shows that the CUSA device can effectively make liver surgeries safer and more efficient. Who this helps: This benefits patients undergoing liver surgery and the surgeons performing the procedures.

Plain English
This study looked at how to predict early cancer recurrence in patients with a specific type of liver cancer called peri-hilar cholangiocarcinoma (PCC) by creating a tool called the Preoperative Recurrence Score (PRS). Researchers found that certain factors, like tumor size over 18 mm and involvement of nearby blood vessels or lymph nodes, significantly increased the risk of cancer returning after surgery. For instance, patients with a high PRS had a one-year recurrence rate of 80% in one group, highlighting the tool's effectiveness in assessing risk before surgery. Who this helps: This helps patients and doctors make better decisions about surgery for liver cancer.

Plain English
Researchers studied how cancer-associated fibroblasts (CAFs) interact with tumor cells in a specific type of liver cancer called intrahepatic cholangiocarcinoma (iCCA). They found that a drug called Crenigacestat effectively reduced tumor growth and invasion by blocking these interactions, leading to a significant decrease in the size of tumors in animal models—specifically, the drugs reduced tumor sizes by an unknown percentage reported in the study. This research is important because it reveals a new target for cancer treatment, which could help slow down the progression of this aggressive cancer. Who this helps: Patients with intrahepatic cholangiocarcinoma.

Plain English
This study looked at how effective different treatments are for patients with early-stage multinodular liver cancer, specifically comparing surgery (liver resection) to nonsurgical methods like radiofrequency ablation and chemoembolization. Among 720 patients, surgery showed better survival rates: 89% survived one year, 71% survived three years, and 56% survived five years, compared to 94%, 65%, and 40% for radiofrequency ablation and 91%, 49%, and 29% for chemoembolization. This matters because it suggests that surgery should be the first option for treating these patients, which can lead to better outcomes. Who this helps: This helps patients with early-stage liver cancer who cannot receive a transplant.

Plain English
This study looked at whether a surgical procedure called lymphadenectomy—removing lymph nodes—improves survival for patients with a type of liver cancer called intrahepatic cholangiocarcinoma (iCCA) who show no signs of lymph node involvement before surgery. The researchers found that among 706 patients, those who had adequate lymphadenectomy (removing 6 or more lymph nodes) lived longer and had less chance of the cancer returning compared to those who had inadequate lymphadenectomy. Specifically, patients with adequate lymphadenectomy had an average overall survival of 39 months compared to 28 months for those later found to have node-positive disease. Who this helps: This benefits patients with intrahepatic cholangiocarcinoma undergoing liver surgery.

Plain English
This study looked at patients who suffered bile duct injuries after gallbladder surgery and how the timing of their referral to specialized care affected the likelihood of lawsuits. Out of 98 patients included, those who were referred late (after 20 days) had a significantly higher risk of facing lawsuits, reaching up to 65.1% depending on the delay. This matters because quicker referral to specialized centers—without attempting repairs first—can help reduce the chances of lawsuits and improve patient outcomes. Who this helps: This helps patients and doctors involved in gallbladder surgery.

Plain English
This study looked at the outcomes of minimally invasive liver surgery for patients with small liver tumors called hepatocellular carcinoma (HCC) that were 3 cm or less in size. Researchers analyzed data from 714 patients and found that 90% were in good health before surgery, with a very low 90-day death rate of just 0.3% and a 5-year survival rate of 79.5%. This research is important because it shows that minimally invasive techniques can safely treat these tumors, encouraging more patients to consider surgery instead of other treatments. Who this helps: This benefits patients with small liver tumors and their doctors by providing a safer surgical option.

Plain English
This study looked at the survival rates of patients with recurrent liver cancer (hepatocellular carcinoma) who received either second-line transplants or other treatments like repeated surgery and thermal ablation. Researchers found that patients who received second-line transplants had a significantly longer survival time, with a median survival of over 43 months compared to those who had repeated surgeries, who lived for 43 months on average. This is important because it highlights the need to refer more patients for second-line transplants, which can offer better outcomes. Who this helps: This benefits patients with recurrent liver cancer and their doctors by providing better treatment options.

Plain English
This study looked at how the timing of surgical repair for bile duct injuries during gallbladder removal affects patient outcomes. Out of 114 patients treated, most (78%) had delayed repairs after six weeks, but all surgeries were successful with no deaths, and 94.7% of patients maintained proper bile flow over the long term. Importantly, the timing of the repair did not impact the rate of successful recovery, especially for patients without complications. Who this helps: This helps patients who experience bile duct injuries during gallbladder surgery.

Plain English
This study focused on creating a machine learning tool that helps doctors choose the best treatment for patients with recurrent liver cancer (hepatocellular carcinoma) after surgery. Researchers analyzed data from 701 patients and found that 87.2% could benefit from reoperation or thermal treatment, while only 5.2% and 7.6% would benefit from other treatments, sorafenib and chemoembolization respectively. This matters because it provides a personalized way to improve survival chances for patients with recurrent liver cancer based on their individual circumstances. Who this helps: This helps patients with recurrent liver cancer and their doctors.

Plain English
This study looked at how using advanced imaging techniques, called radiomics, can help predict important details about intrahepatic cholangiocarcinoma (ICC) tumors before surgery. Researchers analyzed data from 244 patients and found that using radiomic features alongside standard clinical information improved the accuracy of predicting tumor grading and the presence of microvascular invasion. Specifically, the best prediction models had an accuracy of 77% for tumor grading and 75% for microvascular invasion, which is significantly better than methods that only use clinical data. Who this helps: This research benefits doctors and patients by providing more accurate predictions about tumor characteristics, which can guide treatment decisions.

Plain English
This study looked at how a procedure called peroral cholangioscopy (POCS) helps doctors evaluate and plan surgery for growths in the bile ducts. The researchers examined four patients with these growths and found that three of them had lesions that affected the main bile duct area. This information is crucial for creating a tailored surgical plan, as it helps doctors decide how much of the bile duct needs to be removed during surgery. Who this helps: This benefits patients with biliary lesions by providing more accurate surgical planning.